GLP-2TZ 30MG Lyophilized Vial – Mode Peptides
GLP-2TZ is a novel dual-action research compound combining GLP-2 intestinotrophic and Tirzepatide (GIP/GLP-1) pharmacology. Studied for intestinal barrier function, nutrient absorption, gut adaptation, and glycemic control in preclinical models. Supplied as a stable 30MG lyophilized powder.
Specs: 30MG | Purity 99%| Lyophilized Powder
For Research Purposes Only. Not for human or animal consumption.
$159.99 Original price was: $159.99.$118.11Current price is: $118.11.

Today
Today
3 - 7 Days
$10.99 Original price was: $10.99.$8.12Current price is: $8.12.
Mode Peptides GLP-2TZ 30MG is a high-purity synthetic peptide compound supplied as a stable lyophilized powder for advanced metabolic and gastrointestinal research.
GLP-2TZ 30MG is a novel, long-acting dual-action analog engineered from Glucagon-Like Peptide-2 (GLP-2) and Tirzepatide (TZ) pharmacology. Native GLP-2 is an intestinotrophic peptide that enteroendocrine L-cells secrete to regulate intestinal growth and function, while Tirzepatide acts as a dual GIP/GLP-1 receptor agonist with metabolic effects.Researchers use this conjugated research compound to investigate synergistic pathways that govern gut barrier integrity, nutrient absorption, and glycemic control within a single molecular model. Additionally, it serves as a research focus in studies examining intestinal adaptation and metabolic homeostasis. Furthermore, these investigations help researchers explore the relationship between intestinal function and metabolic signaling.
This lyophilized vial format ensures maximum stability, extended shelf-life, and accurate reconstitution for precise dosing in controlled laboratory environments, making it ideal for both in-vitro receptor assays and in vivo preclinical models. Research Use Only.
Researchers use GLP-2TZ 30MG in research models exploring intestinal mucosal growth and villus hypertrophy, intestinal barrier function and tight junction integrity, nutrient absorption efficiency, short bowel syndrome (SBS), chemotherapy-induced intestinal mucositis, glucose-dependent insulin secretion, gastric motility and appetite regulation, and weight management and metabolic syndrome pathways. Additionally, researchers use this compound to study the cross-talk between gut-trophic and incretin systems. Furthermore, these applications help researchers investigate interactions between intestinal function, nutrient handling, and metabolic signaling. Evaluating its potential to enhance intestinal adaptation while simultaneously modulating metabolic parameters. It is a valuable tool for gastroenterology, endocrinology, and metabolic disease research programs.
Each batch includes a Certificate of Analysis (COA). For proper storage, keep the unreconstituted vial at -20°C in a dry, dark environment. Additionally, protect the material from moisture and light. When reconstituting, use only appropriate sterile laboratory diluents under aseptic conditions. After reconstitution, avoid repeated freeze-thaw cycles to help maintain sample integrity. Finally, this material is for research use only.
The GLP-2TZ 30mg Research Product is intended exclusively for controlled laboratory and scientific research. Researchers may study this research material in experimental models involving peptide biology, receptor signaling, metabolic pathways, and related cellular mechanisms. For research use only, this material is not intended for human use, animal use, self-administration, diagnosis, treatment, cure, or prevention of any disease or medical condition. Qualified laboratory personnel should handle and evaluate the material according to established research protocols, institutional requirements, and applicable laboratory safety procedures.
Documentation, not promises.
Rarely
Sometimes
X
X
Varies